This research demonstrates enantioselective recognition in chiral amino acids using a copper(II) complex, highlighting the role of π-π stacking interactions.
The stereoselective recognition of chiral amino acids remains a fundamental challenge in biomimetic chemistry. Here, we report a single crystal of copper(II) coordination complex (C-1), which functions as a receptor, engineered by leveraging π-π stacking interactions as the primary mechanism for discriminating enantiomers of tryptophan (Trp) and histidine (His). Constructed from deoxycytidine monophosphate (dCMP) and 1,10-phenanthroline ligands, C-1 adopts a one-dimensional architecture that selectively binds l- and d-enantiomers through stereospecific aromatic interactions. UV–visible titrations reveal a 10-fold increase in absorbance for l-Trp compared to d-Trp, while circular dichroism (CD) spectra exhibit distinct Cotton effects, directly attributed to π-π stacking between the indole/imidazole side chains and the aromatic framework of C-1. DFT calculations reveal π-π binding energies (−0.49 to −1.20 eV) as the driving force for enantioselective recognition, with geometric alignment enhancing stabilization of both l- and d-enantiomers. By prioritizing π-driven interactions over hydrogen bonding, C-1 achieves precise enantioselectivity, comparable to biological systems. This work establishes π-π stacking as a design principle for synthetic receptors, facilitating adaptive chiral sensing based on noncovalent molecular recognition.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: